Kendall Capital Partners — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
Board seatGeorge M. Church· per SEC Form D · $3M raise · filed Aug 2016
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPKhosla VenturesOUP (Osage University Partners)b2venture
BiotechWatertown, US
Carlo Giovanni Traverso(Director)Amy W. Schulman(Executive Officer, Director)inRobert S. Langer(Director)
BoardZafi Avnur(Director)Edmund Harrigan(Director)Catherine Reynolds(Director)
Board seatRobert Langer· per SEC Form D · $23.1M raise · filed Apr 2017
Co-investorsBill & Melinda Gates FoundationPolaris Partners
BiotechWatertown, US
Omid Farokhzad(Director)Robert S. Langer, Jr.(Director)Andrew J. Fromkin(Executive Officer, Director)Leila Alland(Executive Officer)Richard Wooster(Executive Officer)Omid C. Farokhzad(Director)
Board seatRobert Langer· per SEC Form D · $38M raise · filed Feb 2017
Co-investors+ND Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.